vs
ALLIENT INC（ALNT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
ALLIENT INC的季度营收约是再鼎医药的1.1倍（$143.4M vs $127.1M），ALLIENT INC同比增速更快（17.5% vs 17.1%），ALLIENT INC自由现金流更多（$11.7M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -1.2%）
Allient Inc是一家全球化技术制造企业，主营精密运动、控制及电源解决方案的设计、生产与分销，核心服务航空航天、国防、医疗设备、工业自动化、商用出行等领域，业务覆盖北美、欧洲及亚太地区。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ALNT vs ZLAB — 直观对比
营收规模更大
ALNT
是对方的1.1倍
$127.1M
营收增速更快
ALNT
高出0.4%
17.1%
自由现金流更多
ALNT
多$38.4M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.4M | $127.1M |
| 净利润 | $6.4M | — |
| 毛利率 | 32.4% | 51.0% |
| 营业利润率 | 7.9% | -54.6% |
| 净利率 | 4.5% | — |
| 营收同比 | 17.5% | 17.1% |
| 净利润同比 | 111.8% | — |
| 每股收益（稀释后） | $0.38 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALNTZLAB
| Q4 25 | $143.4M | $127.1M | ||
| Q3 25 | $138.7M | $115.4M | ||
| Q2 25 | $139.6M | $109.1M | ||
| Q1 25 | $132.8M | $105.7M | ||
| Q4 24 | $122.0M | $108.5M | ||
| Q3 24 | $125.2M | $101.8M | ||
| Q2 24 | $136.0M | $100.1M | ||
| Q1 24 | $146.7M | $87.1M |
净利润ALNTZLAB
| Q4 25 | $6.4M | — | ||
| Q3 25 | $6.5M | $-36.0M | ||
| Q2 25 | $5.6M | $-40.7M | ||
| Q1 25 | $3.6M | $-48.4M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $2.1M | $-41.7M | ||
| Q2 24 | $1.1M | $-80.3M | ||
| Q1 24 | $6.9M | $-53.5M |
毛利率ALNTZLAB
| Q4 25 | 32.4% | 51.0% | ||
| Q3 25 | 33.3% | 59.5% | ||
| Q2 25 | 33.2% | 60.6% | ||
| Q1 25 | 32.2% | 63.6% | ||
| Q4 24 | 31.5% | 61.5% | ||
| Q3 24 | 31.4% | 64.1% | ||
| Q2 24 | 29.9% | 64.9% | ||
| Q1 24 | 32.3% | 61.4% |
营业利润率ALNTZLAB
| Q4 25 | 7.9% | -54.6% | ||
| Q3 25 | 8.8% | -42.3% | ||
| Q2 25 | 8.4% | -50.3% | ||
| Q1 25 | 6.6% | -53.3% | ||
| Q4 24 | 5.3% | -62.6% | ||
| Q3 24 | 5.3% | -66.6% | ||
| Q2 24 | 3.6% | -76.0% | ||
| Q1 24 | 8.2% | -80.7% |
净利率ALNTZLAB
| Q4 25 | 4.5% | — | ||
| Q3 25 | 4.7% | -31.2% | ||
| Q2 25 | 4.0% | -37.3% | ||
| Q1 25 | 2.7% | -45.8% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 1.7% | -40.9% | ||
| Q2 24 | 0.8% | -80.2% | ||
| Q1 24 | 4.7% | -61.4% |
每股收益（稀释后）ALNTZLAB
| Q4 25 | $0.38 | $-0.05 | ||
| Q3 25 | $0.39 | $-0.03 | ||
| Q2 25 | $0.34 | $-0.04 | ||
| Q1 25 | $0.21 | $-0.04 | ||
| Q4 24 | $0.17 | $-0.09 | ||
| Q3 24 | $0.13 | $-0.04 | ||
| Q2 24 | $0.07 | $-0.08 | ||
| Q1 24 | $0.42 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.7M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.5M | $715.5M |
| 总资产 | $577.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALNTZLAB
| Q4 25 | $40.7M | $689.6M | ||
| Q3 25 | $39.5M | $717.2M | ||
| Q2 25 | $49.9M | $732.2M | ||
| Q1 25 | $47.8M | $757.3M | ||
| Q4 24 | $36.1M | $779.7M | ||
| Q3 24 | $37.1M | $616.1M | ||
| Q2 24 | $31.3M | $630.0M | ||
| Q1 24 | $31.5M | $650.8M |
股东权益ALNTZLAB
| Q4 25 | $301.5M | $715.5M | ||
| Q3 25 | $294.2M | $759.9M | ||
| Q2 25 | $289.1M | $791.7M | ||
| Q1 25 | $272.8M | $810.8M | ||
| Q4 24 | $264.9M | $840.9M | ||
| Q3 24 | $272.9M | $667.7M | ||
| Q2 24 | $265.7M | $704.2M | ||
| Q1 24 | $267.1M | $762.2M |
总资产ALNTZLAB
| Q4 25 | $577.6M | $1.2B | ||
| Q3 25 | $585.1M | $1.2B | ||
| Q2 25 | $588.1M | $1.2B | ||
| Q1 25 | $586.9M | $1.2B | ||
| Q4 24 | $575.8M | $1.2B | ||
| Q3 24 | $596.4M | $985.3M | ||
| Q2 24 | $595.8M | $987.4M | ||
| Q1 24 | $611.6M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.6M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $11.7M | $-26.7M |
| 自由现金流率自由现金流/营收 | 8.1% | -21.0% |
| 资本支出强度资本支出/营收 | 1.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.12× | — |
| 过去12个月自由现金流最近4个季度 | $49.7M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ALNTZLAB
| Q4 25 | $13.6M | $-26.0M | ||
| Q3 25 | $4.7M | $-32.0M | ||
| Q2 25 | $24.5M | $-31.0M | ||
| Q1 25 | $13.9M | $-61.7M | ||
| Q4 24 | $12.4M | $-55.8M | ||
| Q3 24 | $12.1M | $-26.8M | ||
| Q2 24 | $8.2M | $-42.2M | ||
| Q1 24 | $9.2M | $-90.1M |
自由现金流ALNTZLAB
| Q4 25 | $11.7M | $-26.7M | ||
| Q3 25 | $2.8M | $-35.0M | ||
| Q2 25 | $22.4M | $-33.9M | ||
| Q1 25 | $12.9M | $-63.2M | ||
| Q4 24 | $9.6M | $-58.4M | ||
| Q3 24 | $10.5M | $-28.2M | ||
| Q2 24 | $5.8M | $-42.9M | ||
| Q1 24 | $6.2M | $-91.1M |
自由现金流率ALNTZLAB
| Q4 25 | 8.1% | -21.0% | ||
| Q3 25 | 2.0% | -30.4% | ||
| Q2 25 | 16.0% | -31.1% | ||
| Q1 25 | 9.7% | -59.9% | ||
| Q4 24 | 7.9% | -53.8% | ||
| Q3 24 | 8.4% | -27.7% | ||
| Q2 24 | 4.3% | -42.9% | ||
| Q1 24 | 4.2% | -104.5% |
资本支出强度ALNTZLAB
| Q4 25 | 1.3% | 0.5% | ||
| Q3 25 | 1.4% | 2.6% | ||
| Q2 25 | 1.5% | 2.6% | ||
| Q1 25 | 0.8% | 1.5% | ||
| Q4 24 | 2.3% | 2.4% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 1.7% | 0.7% | ||
| Q1 24 | 2.0% | 1.1% |
现金转化率ALNTZLAB
| Q4 25 | 2.12× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 4.36× | — | ||
| Q1 25 | 3.92× | — | ||
| Q4 24 | 4.11× | — | ||
| Q3 24 | 5.75× | — | ||
| Q2 24 | 7.13× | — | ||
| Q1 24 | 1.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALNT
| Industrial And Electronics | $69.5M | 48% |
| Vehicle | $25.7M | 18% |
| Other | $20.9M | 15% |
| Aerospace And Defense | $20.6M | 14% |
| Distribution And Other Target Market | $6.7M | 5% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
